Gerald Fletcher is the editor of Obesity: Impact on Cardiovascular Disease, published by Wiley.Scott Grundy is the editor of Obesity: Impact on Cardiovascular Disease, published by Wiley.Laura Hayman is the editor of Obesity: Impact on Cardiovascular Disease, published by Wiley.

"This is a superb and needed book."—American Journal of Cardiology"This book may best be considered an excellent update on obesity."—Texas Heart Institute Journal"Excellent Four Stars. A comprehensive review of an important clinical area in which treatment options are badly needed."—Mayo Clinic Proceedings

• Contributors. Acknowledgement.Preface. (S.M. Grundy).Part 1: Epidemiology of Obesity.Chapter 1. Epidemiology of Obesity in Adults in Relationship to Cardiovascular Disease. (L.H. Kuller).Chapter 2. Obesity in Children, Adolescents and Families. (E. Obarzanek).Chapter 3. Developmental Aspects of Obesity: Genetic Influences. (T.L. Burns).Chapter 4. Developmental Aspects of Obesity: Nongenetic Influences. (L.L. Hayman).Chapter 5. Prevention of Obesity. (S.R. Daniels).Part 2: Pathophysiology of Disease.Chapter 6. Obesity Related Genes. (R.M. Krauss).Chapter 7. Diet Drugs and Valvular Heart DIsease. (G.P. Aurigemma).Chapter 8. Mechanisms of Obesity Hypertension and Relevance to Essential Hypertension. (J.E. Hall, M.W. Brands, D.W. Jones, E.W. Shek, J. Henegar).Chapter 9. Obesity and Lipoprotein Metabolism: Relationship to Cardiovascular Disease. (B.V. Howard).Chapter 10. Is Insulin Resistance and Independent Risk Factor for Coronary Heart Disease? (S.M. Grundy).Chapter 11. Obesity and Postmenopausal Women. (K.M. Newton).Chapter 12. Late Breaking Advances in the Biological Understanding of Obesity and its Sequelae. (R.H. Eckel).Part 3: Assessment, Interventions, Treatment and Outcomes.Chapter 13. Body Composition Assessment: Epidemiological, Clinical and Research Tools. (M.E. Sweeney).Chapter 14. Dietary Strategies: Issues of Diet Composition. (S.T. St. Jeor, J.M. Ashley).Chapter 15. Energy Expenditure and Obesity. (J.O. Hill, Adamandia D. Kriketos).Chapter 16. Physical Activity in the Management of Obesity: Issues and Implementation. (M.L. Stefanick).Chapter 17. Efficacy and Safety of Pharmacological Interventions for the Overweight Patient. (G.A. Bray).Chapter 18. Behavioural Interaction. (J.P. Foreyt, W.S. Carlos Poston).Chapter 19. Strategies to Enhance Compliance to Weight-Loss Treatment. (L.E. Burke).Chapter 20. Quality of Life and Obesity. (M.R. Kinney).Chapter 21. Economic Impact of Obesity and its Cardiovascular Sequelae in Managed Care Settings. (K. McManus).Summary. (G.F. Fletcher).Index.

Gerald Fletcher is the editor of Obesity: Impact on Cardiovascular Disease, published by Wiley.Scott Grundy is the editor of Obesity: Impact on Cardiovascular Disease, published by Wiley.Laura Hayman is the editor of Obesity: Impact on Cardiovascular Disease, published by Wiley.

"This is a superb and needed book."—American Journal of Cardiology"This book may best be considered an excellent update on obesity."—Texas Heart Institute Journal"Excellent Four Stars. A comprehensive review of an important clinical area in which treatment options are badly needed."—Mayo Clinic Proceedings

• Contributors. Acknowledgement.Preface. (S.M. Grundy).Part 1: Epidemiology of Obesity.Chapter 1. Epidemiology of Obesity in Adults in Relationship to Cardiovascular Disease. (L.H. Kuller).Chapter 2. Obesity in Children, Adolescents and Families. (E. Obarzanek).Chapter 3. Developmental Aspects of Obesity: Genetic Influences. (T.L. Burns).Chapter 4. Developmental Aspects of Obesity: Nongenetic Influences. (L.L. Hayman).Chapter 5. Prevention of Obesity. (S.R. Daniels).Part 2: Pathophysiology of Disease.Chapter 6. Obesity Related Genes. (R.M. Krauss).Chapter 7. Diet Drugs and Valvular Heart DIsease. (G.P. Aurigemma).Chapter 8. Mechanisms of Obesity Hypertension and Relevance to Essential Hypertension. (J.E. Hall, M.W. Brands, D.W. Jones, E.W. Shek, J. Henegar).Chapter 9. Obesity and Lipoprotein Metabolism: Relationship to Cardiovascular Disease. (B.V. Howard).Chapter 10. Is Insulin Resistance and Independent Risk Factor for Coronary Heart Disease? (S.M. Grundy).Chapter 11. Obesity and Postmenopausal Women. (K.M. Newton).Chapter 12. Late Breaking Advances in the Biological Understanding of Obesity and its Sequelae. (R.H. Eckel).Part 3: Assessment, Interventions, Treatment and Outcomes.Chapter 13. Body Composition Assessment: Epidemiological, Clinical and Research Tools. (M.E. Sweeney).Chapter 14. Dietary Strategies: Issues of Diet Composition. (S.T. St. Jeor, J.M. Ashley).Chapter 15. Energy Expenditure and Obesity. (J.O. Hill, Adamandia D. Kriketos).Chapter 16. Physical Activity in the Management of Obesity: Issues and Implementation. (M.L. Stefanick).Chapter 17. Efficacy and Safety of Pharmacological Interventions for the Overweight Patient. (G.A. Bray).Chapter 18. Behavioural Interaction. (J.P. Foreyt, W.S. Carlos Poston).Chapter 19. Strategies to Enhance Compliance to Weight-Loss Treatment. (L.E. Burke).Chapter 20. Quality of Life and Obesity. (M.R. Kinney).Chapter 21. Economic Impact of Obesity and its Cardiovascular Sequelae in Managed Care Settings. (K. McManus).Summary. (G.F. Fletcher).Index.